Crinetics Pharmaceuticals, Inc. (CRNX)

SEC filing

Crinetics Pharmaceuticals, Inc.

CRNX · CIK 1658247

4 · Dec 3, 2025 · Pizzuti Dana sold 5,000 shares at $45.02/share ($225.1K); exercised options for 5,000 shares

Pizzuti Dana sold 5,000 shares at $45.02/share ($225.1K); exercised options for 5,000 shares

FORM 4

xslF345X05/wk-form4_1764797309.xmlSEC.gov

Graphics and non-inline formats (not embedded below).